Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Andrographolide

Andrographis paniculata (Andrographolide) · also known as Andrographolide, Andrographis extract, Andrographolide

In cell and animal experiments, andrographolide can bind covalently to Cys62 of the NF-κB p50 subunit and inhibit its activation. There is no direct evidence on whether this target is occupied in humans. Human studies so far have only measured blood levels of the compound after oral dosing.

Typical dose: Standardized andrographolide 300–600 mg/day (in 2–3 divided doses) for 3–7 consecutive days
Absorption and forms: Andrographolide is very bitter and can be detected in blood after oral dosing. Its reported half-life is about 2–3 hours, but its pharmacokinetics vary with formulation and dose, so half-life alone is not enough to set a fixed dosing interval.

Clinical uses and human evidence

Colds: prevention and duration

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Hu 2017 · PLoS One · Meta-analysis · n=7175 — Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis

Osteoarthritis pain

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Hancke 2019 · Phytother Res · RCT · n=103 — A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis

Mechanisms of action

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★★☆☆Mechanism evidence: grade CPrimary target

The unsaturated lactone ring of andrographolide can covalently modify cysteine 62 of the NF-κB p50 subunit, inhibiting its activation in cell and animal experiments. Whether this target is occupied in humans has not been measured directly, and the extent of modification after oral dosing is uncertain.

References (2)
  1. Xia 2004 · Cell and animal study: andrographolide can modify p50 at Cys62 and inhibit related NF-κB activation
  2. 2000 study · Human and rat pharmacokinetic study: measurable andrographolide exposure after oral dosing, but this alone does not show that p50 is modified in humans

Pattern recognition receptor (PRR) immune surveillance and trained immunity

★☆☆☆☆Mechanism evidence: grade DSecondary target

Changes in markers such as lymphocyte proliferation and NK cell counts do not show that pattern recognition receptors are activated or that trained immunity develops. Some animal studies instead show reduced TLR4-related signaling, and there is currently no reliable evidence supporting this mechanism.

References (2)
  1. 2021 study · Open-label human study: peripheral immune cell markers were observed, with no placebo group and no test of pattern recognition receptor training
  2. 2023 study · Mouse study: andrographolide can suppress TLR4/NF-κB-related inflammatory signaling

Safety and drug interactions

Contraindicated in pregnancy: animal studies have shown possible anti-implantation and abortifacient effects, and human risk data are insufficient. Some people may experience reduced appetite or diarrhea. It can be stopped once symptoms ease. Andrographis can cause severe allergic reactions, even anaphylactic shock. If signs of an allergy appear, stop immediately and seek medical care.

Immune stimulation

Has immunomodulating effects. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.

Open in the interactive app ›